#sars cov 2

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral ...

The number of patients having made a recovery from the coronavirus disease (COVID-19), caused by the SARS-CoV-2 virus, ...

Indonesia’s indigenous Red-and-White coronavirus vaccine, which is currently under development, will target all ...

The COVID-19 Handling Task Force announced that 4,838,752 people received the COVID-19 vaccine in Indonesia as of March ...

The number of Indonesians receiving their first dose of the COVID-19 vaccine rose by 216,422 to reach 3,985,596 as of ...

Health Minister Budi Gunadi Sadikin spoke of his plan to administer 1.5 million COVID-19 vaccine shots every day in the ...

The COVID-19 vaccine that is currently being used in Indonesia is effective against the B1.1.7 variant, which is ...

SARS-CoV 2 causing the coronavirus disease (COVID-19) can last inside a surgical mask for seven days and its front or ...

The mutation of the SARS-CoV-2 virus, which causes COVID-19, is affecting the efficacy of vaccines, Minister of ...

The COVID-19 Handling Task Force made an earnest appeal to survivors of the coronavirus disease (COVID-19) to come ...

Takex Co., Ltd., (President and CEO: Hisayuki Okada), engaged in R&D in Bamboo since developing the original ...

Indonesia has so far vaccinated 539,532 healthcare workers against COVID-19 in 92 districts and cities across 34 ...

The Health Ministry has claimed 482,145 of the 1,530,308 medical workers targeted under the national immunization ...

Indonesia’s COVID-19 vaccination program for citizens must focus on densely-populated areas with a high infection ...

Head of the COVID-19 Handling Task Force Doni Monardo tested positive for the novel coronavirus that causes ...